Delivery Order SPE2DB25D7060-SPE2DB25FXSSK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Fenofibrate 145 mg tablets in quantities of 90 units, with a ceiling value of $24,586.18. This is a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,454.25 for 90 tablets of Fenofibrate 145 mg on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $107,703.25, is for the delivery of Fenofibrate 145 mg tablets over the period ending on April 4, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,885.87 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of 500 units of 145 mg Fenofibrate tablets to a location in Conshohocken, Pennsylvania. The contract has a completion date of February 9, 2024. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,466.45, is for the delivery of Fenofibrate 145 mg tablets. It is a firm fixed-price delivery order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,658.44 firm-fixed-price delivery order is for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,453.62 firm fixed-price delivery order is for the supply of Fenofibrate 145 mg tablets. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,410.24 firm fixed price delivery order (SPE2DB22D3011|SPE2DB24FQ0PL) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564261717 Fenofibrate 145 mg Tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
- This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL25Q, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,553.99 firm fixed-price delivery order is for the supply of 4563689488 Fenofibrate 145 mg tablets, with a completion date of February 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $19,636.30, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Fenofibrate 145 mg tablets in quantities of 90s. It is a firm-fixed-price delivery order contract with a period of performance running through March 6, 2025. The contract was awarded on March 5, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSSKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Fenofibrate 120 mg tablets (90-count units) with a ceiling value of $26,126.95. The contract employs firm fixed pricing and is classified as a non-set-aside, competitively awarded delivery order, with an ultimate completion date of August 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract award demonstrates AmerisourceBergen Drug Corp's demonstrated capability to fulfill federal pharmaceutical procurement requirements through open competition and its significant role in the DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 8/22/25 |